7th Apr 2014 10:57
LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect.
e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the company's financial controller since January 2012.
Stockdale is a chartered accountant, and was previously a senior manager at Deloitte.
The company said it will make an announcement concerning succession in due course.
Shares in e-Therapeutics were trading 0.5% lower at 22.88 pence per share Monday midday.
By Rowena Harris-Doughty; [email protected]; @rharrisdoughty
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
ETX.L